A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer

被引:0
|
作者
N. Ramnath
S. Daignault-Newton
G. K. Dy
J. R. Muindi
A. Adjei
V. L. Elingrod
G. P. Kalemkerian
K. B. Cease
P. J. Stella
D. E. Brenner
S. Troeschel
C. S. Johnson
D. L. Trump
机构
[1] University of Michigan Comprehensive Cancer Center,Division of Medical Oncology, Department of Internal Medicine
[2] University of Michigan,Biostatistics Core, Comprehensive Cancer Center
[3] Veterans Administration Ann Arbor Healthcare System,Departments of Medicine and Pharmacology
[4] Roswell Park Cancer Institute,College of Pharmacy
[5] University of Michigan,undefined
[6] St. Joseph’s Hospital,undefined
来源
关键词
Calcitriol; Lung cancer; CYP24A1-SNPs;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1173 / 1182
页数:9
相关论文
共 50 条
  • [1] A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer
    Ramnath, N.
    Daignault-Newton, S.
    Dy, G. K.
    Muindi, J. R.
    Adjei, A.
    Elingrod, V. L.
    Kalemkerian, G. P.
    Cease, K. B.
    Stella, P. J.
    Brenner, D. E.
    Troeschel, S.
    Johnson, C. S.
    Trump, D. L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1173 - 1182
  • [2] Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer
    Zalcberg, J
    Millward, M
    Bishop, J
    McKeage, M
    Zimet, A
    Toner, G
    Friedlander, M
    Barter, C
    Rischin, D
    Loret, C
    James, R
    Bougon, N
    Berille, J
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1948 - 1953
  • [3] A phase II study of docetaxel and infusional cisplatin in advanced non-small-cell lung cancer
    Mori, K
    Kamiyama, Y
    Kondo, T
    Kano, Y
    Kodama, T
    CHEMOTHERAPY, 2005, 51 (2-3) : 120 - 125
  • [4] Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer
    Mori, K
    Kamiyama, Y
    Kondo, T
    Kano, Y
    Tominaga, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (02) : 129 - 132
  • [5] Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer
    Kiyoshi Mori
    Yukari Kamiyama
    Tetsuro Kondo
    Yasuhiko Kano
    Keigo Tominaga
    Cancer Chemotherapy and Pharmacology, 2004, 53 : 129 - 132
  • [6] Phase I/II and Pharmacokinetic Study of Intravenous Vinflunine in Combination With Cisplatin for the Treatment of Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer
    Souquet, Pierre-Jean
    Krzakowski, Maciej
    Ramlau, Rodrig
    Sun, Xu-Shan
    Lopez-Vivanco, Guillermo
    Puozzo, Christian
    Pouget, Jean Christophe
    Pinel, Marie Claire
    Rosell, Rafael
    CLINICAL LUNG CANCER, 2010, 11 (02) : 105 - 113
  • [7] A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study
    Masahiro Tabata
    Toshiyuki Kozuki
    Hiroshi Ueoka
    Katsuyuki Kiura
    Shingo Harita
    Atsuhiko Tada
    Takuo Shibayama
    Nagio Takigawa
    Toshiro Yonei
    Kenichi Gemba
    Yoshihiko Segawa
    Daizo Kishino
    Shinya Tada
    Shunkichi Hiraki
    Mitsune Tanimoto
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 53 - 59
  • [8] A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study
    Tabata, Masahiro
    Kozuki, Toshiyuki
    Ueoka, Hiroshi
    Kiura, Katsuyuki
    Harita, Shingo
    Tada, Atsuhiko
    Shibayama, Takuo
    Takigawa, Nagio
    Yonei, Toshiro
    Gemba, Kenichi
    Segawa, Yoshihiko
    Kishino, Daizo
    Tada, Shinya
    Hiraki, Shunkichi
    Tanimoto, Mitsune
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 53 - 59
  • [9] Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer
    Toshiyuki Tsunoda
    Tomonobu Koizumi
    Muneharu Hayasaka
    Kazuya Hirai
    Shigeru Koyama
    Yasuki Takabayashi
    Keisaku Fujimoto
    Keishi Kubo
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 173 - 177
  • [10] Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer
    Tsunoda, T
    Koizumi, T
    Hayasaka, M
    Hirai, K
    Koyama, S
    Takabayashi, Y
    Fujimoto, K
    Kubo, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (02) : 173 - 177